BOCIC(SH:601696) Xin Lang Cai Jing·2025-10-15 03:40Group 1 - The core viewpoint of the news is that Beijing Baipusi Biotechnology Co., Ltd. has seen a stock price increase of 5.1%, reaching 57.66 yuan per share, with a total market capitalization of 9.678 billion yuan as of October 15 [1] - The company was established on July 22, 2010, and went public on October 18, 2021, focusing on providing key biological reagent products and technical services, with main revenue sources being recombinant proteins (82.27%), antibodies and other reagents (12.88%), technical services (3.04%), and others (1.80%) [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in Baipusi, with the Bank of China Health Industry Mixed Fund (002938) owning 99,000 shares, accounting for 4.48% of the fund's net value, ranking as the seventh largest holding [2] - The fund has achieved a year-to-date return of 38.15%, ranking 1616 out of 8161 in its category, and a one-year return of 26.65%, ranking 2855 out of 8015 [2] Group 3 - The fund manager of the Bank of China Health Industry Mixed Fund is Li Mingwei, who has been in the position for 2 years and 237 days, with the fund's total asset size being 158 million yuan [3]